Retraction notices

2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

Type

Retraction

Notice date

6/22/2022 0:00

Journal

Carcinogenesis

Publisher

Oxford University Press

Notice DOI

10.1093/carcin/bgac038

Original paper DOI

10.1093/carcin/bgq234

Reasons

• Error in Analyses
• Error in Data

Matching venue names

Name match only, not an authoritative journal identifier.

• Carcinogenesis